The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.



Source: ADnet
Source Link: https://www.zdnet.com/article/a-drug-developer-is-buying-23andme-what-does-that-mean-for-your-dna-data/